These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 10615346)
1. First, do no harm: naltrexone-accelerated detoxification. Gaughwin MD Med J Aust; 1999 Nov; 171(9):499. PubMed ID: 10615346 [No Abstract] [Full Text] [Related]
2. Depot naltrexone use for opioid dependence in Australia: large-scale use of an unregistered medication in the absence of data on safety and efficacy. Degenhardt L; Gibson A; Mattick RP; Hall W Drug Alcohol Rev; 2008 Jan; 27(1):1-3. PubMed ID: 18034375 [No Abstract] [Full Text] [Related]
3. An ethical framework for conducting research on pregnant, opioid-dependent women. McCullough LB; Chervenak FA; Coverdale JH Addiction; 2013 Feb; 108(2):248-9. PubMed ID: 23331876 [No Abstract] [Full Text] [Related]
4. Naltrexone in the treatment of opioid-dependent pregnant women: common ground. Jones HE; Chisolm MS; Jansson LM; Terplan M Addiction; 2013 Feb; 108(2):255-6. PubMed ID: 23331881 [No Abstract] [Full Text] [Related]
5. [Limited role of naltrexone in the treatment of opiate addiction]. van Brussel GH Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1452-6. PubMed ID: 11503313 [TBL] [Abstract][Full Text] [Related]
7. Methods of detoxification and their role in treating patients with opioid dependence. O'Connor PG JAMA; 2005 Aug; 294(8):961-3. PubMed ID: 16118388 [No Abstract] [Full Text] [Related]
8. [A review of naltrexone maintenance programs: effectiveness, predictors and profile]. Madoz-Gúrpide A; Ochoa E; Baca-García E Med Clin (Barc); 2002 Sep; 119(9):351-5. PubMed ID: 12356367 [No Abstract] [Full Text] [Related]
10. Detoxification and treating opioid dependence. de Jong CJ JAMA; 2006 Feb; 295(8):887; author reply 887-8. PubMed ID: 16493098 [No Abstract] [Full Text] [Related]
11. The rationale for naltrexone therapy as an alternative to methadone treatment for opiate addiction. Simon DL Conn Med; 1996 Nov; 60(11):683-5. PubMed ID: 8979434 [No Abstract] [Full Text] [Related]
12. Outcomes of naltrexone maintenance following ultra rapid opiate detoxification versus intensive inpatient detoxification. Rabinowitz J; Cohen H; Atias S Am J Addict; 2002; 11(1):52-6. PubMed ID: 11876583 [TBL] [Abstract][Full Text] [Related]
14. Circumstances of death of opioid users being treated with naltrexone. Darke S; Farrell M; Duflou J; Larance B; Lappin J Addiction; 2019 Nov; 114(11):2000-2007. PubMed ID: 31278812 [TBL] [Abstract][Full Text] [Related]
15. [Alcohol consumption in opioid-dependence patients in treatment with naltrexone]. Ochoa Mangado E; Arias Horcajadas F Actas Esp Psiquiatr; 2000; 28(4):239-49. PubMed ID: 11116795 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness, Implementation and Real-World Experience with Extended-Release Naltrexone (XR-NTX): A Special Issue of JSAT. Friedmann PD; Dunn KE; Nunes EV; O'Brien CP J Subst Abuse Treat; 2018 Feb; 85():31-33. PubMed ID: 29273249 [No Abstract] [Full Text] [Related]
17. Diagnosis and Treatment of Opioid Use Disorder in 2020. Wakeman SE JAMA; 2020 May; 323(20):2082-2083. PubMed ID: 32329798 [No Abstract] [Full Text] [Related]
19. Risks associated with the inappropriate use of naltrexone in the treatment of opioid dependence. Latt NC Med J Aust; 1999 Nov; 171(9):500-1. PubMed ID: 10615348 [No Abstract] [Full Text] [Related]
20. Dual dilemma-should naltrexone be used in the treatment of opioid-dependent pregnant women? Stitzer ML Addiction; 2013 Feb; 108(2):249-50. PubMed ID: 23331877 [No Abstract] [Full Text] [Related] [Next] [New Search]